Politics News

• Miami,  Finance,  Medical,  Health,  Marketing,  Banking,  Media,  Biotech,  Stocks,  Stock Market,  Financial,  Nasdaq

  $750 Million Ketamine Drug Market Withing Reach via New Commissioner's National Priority Vouchers with Anticipated Approval by Year-End for NRx
• Miami,  Finance,  Medical,  Health,  Marketing,  Banking,  Media,  Biotech,  Stocks,  Stock Market,  Financial,  Nasdaq

  $750 Million Market Projected to Reach $3.3 Billion Globally in 2034 for New Drug Application Filed on Preservative-Free IV Ketamine: NRx Pharma, Inc
• Miami,  Finance,  Medical,  Health,  Marketing,  Banking,  Media,  Biotech,  Stocks,  Stock Market,  Financial,  Nasdaq

  CEO Selected to Present at Wall Street Conference on May 21, 2025 for Suicidal Depression / PTSD: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
• Miami,  Finance,  Medical,  Health,  Marketing,  Banking,  Media,  Biotech,  Stocks,  Stock Market,  Financial,  Nasdaq

  $7.8M Financing Boosts NRx's Expansion with Kadima Institute Acquisition for PTSD and Depression Care: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
• Miami,  Finance,  Medical,  Health,  Marketing,  Banking,  Media,  Biotech,  Stocks,  Stock Market,  Financial,  Nasdaq

  Plan Signed to Purchase Kadima Neuropsychiatry Institute as Clinical Treatment Model and Leading Investigative Site Addressing Suicidal Depression
• West Palm Beach,  Government

  League of Women Voters PBC to Host 'Hot Topic Luncheon' in Lake Worth, May 21
• Miami,  Finance,  Medical,  Health,  Marketing,  Banking,  Media,  Biotech,  Stocks,  Stock Market,  Financial,  Nasdaq

  $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
• Miami,  Finance,  Medical,  Health,  Marketing,  Banking,  Media,  Biotech,  Stocks,  Stock Market,  Financial,  Nasdaq

  $4.3 Million Waiver Exemption Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression, PTSD: NRx: Stock Symbol: NRXP